European Journal of Cancer
Volume 41, Issue 17 , Pages 2682-2689 , November 2005

Multi-centre pilot study of 2-chlorodeoxyadenosine and cytosine arabinoside combined chemotherapy in refractory Langerhans cell histiocytosis with haematological dysfunction

  • F. Bernard

      Affiliations

    • Service d’Hémato-Oncologie Pédiatrique, Hôpital Arnaud de Villeneuve, CHU de Montpellier, 34000 Montpellier, France
    • Corresponding Author InformationCorresponding author. Tel.: +33 4 67 33 66 03.
  • ,
  • C. Thomas

      Affiliations

    • Service d’Hémato-Oncologie Pédiatrique, Hôtel Dieu, CHU de Nantes, Quai Montcousu, 44000 Nantes, France
  • ,
  • Y. Bertrand

      Affiliations

    • Service d’Hématologie Pédiatrique, Hôpital Debrousse, 29 rue Sœur Bouvier, Lyon, France
  • ,
  • M. Munzer

      Affiliations

    • Service d’Hémato-Oncologie Pédiatrique, CHU de Reims, France
  • ,
  • J. Landman Parker

      Affiliations

    • Service d’Hémato-Oncologie Pédiatrique, Hôpital Trousseau, 75012, France
  • ,
  • M. Ouache

      Affiliations

    • Unité d’Immuno-Hématologie, Département de Pédiatrie, Hôpital Necker 75015 Paris, France
  • ,
  • V. Minard Colin

      Affiliations

    • Unité d’Immuno-Hématologie, Département de Pédiatrie, Hôpital Necker 75015 Paris, France
  • ,
  • Y. Perel

      Affiliations

    • Service de Médecine Infantile, CHU Pellegrin, Bordeaux, France
  • ,
  • P. Chastagner

      Affiliations

    • Service de Médecine Infantile II, Hopitaux de Brabois, Vandoeuvre les Nancy Cedex, France
  • ,
  • C. Vermylen

      Affiliations

    • Service d’Hémato-Oncologie Pédiatrique, CHU Bruxelles, Belgium
  • ,
  • J. Donadieu

      Affiliations

    • Service d’Hémato-Oncologie Pédiatrique, Hôpital Trousseau, 75012, France

Received 30 December 2003 ,Revised 2 November 2004 ,Accepted 7 February 2005.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0959-8049(05)00154-1

doi: 10.1016/j.ejca.2005.02.007

European Journal of Cancer
Volume 41, Issue 17 , Pages 2682-2689 , November 2005